Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Woebot Health is a leading digital mental health company dedicated to making mental healthcare radically accessible. Founded on principles of clinical psychology and powered by advanced AI, Woebot offers engaging, evidence-based therapeutic solutions through a relational agent named Woebot. The platform aims to provide continuous emotional support, help users develop coping skills, and bridge gaps in traditional mental healthcare delivery. Woebot Health focuses on conditions like depression, anxiety, and substance use, offering personalized care anytime, anywhere.
Serves as the central hub for leadership, research and development, product innovation, and core business operations.
Modern, open-concept office space designed for collaboration and innovation, featuring technology-enabled meeting rooms and amenities that support employee well-being. Situated in a prominent downtown San Francisco building.
A dynamic, mission-driven, and collaborative environment. The culture fosters innovation in AI and mental health, emphasizing continuous learning, psychological safety, and a commitment to scientific rigor. Employees often describe it as impactful and patient-focused.
San Francisco's rich ecosystem of tech talent, research institutions, and venture capital makes it an ideal location for Woebot Health's pioneering work in AI-driven behavioral health. Proximity to partners and thought leaders in both technology and healthcare.
Woebot Health's platform supports users globally by providing AI-driven mental health tools accessible via smartphones and web. This includes personalized conversational support, mood tracking, and evidence-based therapeutic techniques. The company also engages in global research collaborations and partnerships to advance digital mental health, with a primary operational presence in North America and commercial activities extending into Europe.
600 California Street
San Francisco
CA
USA
Address: 70 Sir John Rogerson's Quay, Dublin 2, D02 R296
To expand Woebot Health's reach and accessibility in Europe, navigate regional healthcare landscapes, and engage with the European market for AI-driven mental health solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Woebot Health' leadership includes:
Woebot Health has been backed by several prominent investors over the years, including:
Over the past 12-18 months, Woebot Health has experienced strategic leadership changes, particularly within its commercial team, aimed at bolstering market expansion and growth. This included the appointment of a new Chief Commercial Officer.
Discover the tools Woebot Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Woebot Health commonly uses an email format combining the first initial with the last name. While other formats might exist within the organization, this is a frequently observed pattern for professional communication at technology and health-tech companies.
[first_initial][last]@woebothealth.com
Format
jdoe@woebothealth.com
Example
85%
Success rate
PR Newswire • November 8, 2023
Woebot Health shared encouraging outcomes from its pivotal clinical trial for WB001, an investigational digital therapeutic designed for women experiencing postpartum depression (PPD). The study demonstrated significant improvements in PPD symptoms for users of WB001....more
Business Wire • July 13, 2023
The U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Woebot Health's investigational digital therapeutic WB001, intended for the treatment of postpartum depression. This designation aims to expedite the development and review of medical devices that offer more effective treatment for life-threatening or irreversibly debilitating diseases....more
PR Newswire • April 12, 2023
Woebot Health announced the appointment of David C. Ayers as its new Chief Commercial Officer. Ayers brings extensive experience in healthcare commercialization and is tasked with leading the company's commercial strategy and market expansion efforts....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Woebot Health, are just a search away.